Cited by

• Ascl2 activation by YAP1/KLF5 ensures the self-renewability of colon cancer progenitor cells.

  Wei X, Ye J, Shang Y, Chen H, Liu S, Liu L, Wang R. Wei X, et al. Oncotarget. 2017 Nov 27;8(65):109301-109318. doi: 10.18632/oncotarget.22673. eCollection 2017 Dec 12. Oncotarget. 2017. PMID: 29312609 Free PMC article.
• Elevated ASCL2 expression in breast cancer is associated with the poor prognosis of patients.

  Xu H, Zhao XL, Liu X, Hu XG, Fu WJ, Li Q, Wang Y, Ping YF, Zhang X, Bian XW, Yao XH. Xu H, et al. Am J Cancer Res. 2017 Apr 1;7(4):955-961. eCollection 2017. Am J Cancer Res. 2017. PMID: 28469967 Free PMC article.
• Ascl2 knockdown results in tumor growth arrest by miRNA-302b-related inhibition of colon cancer progenitor cells.

  Zhu R, Yang Y, Tian Y, Bai J, Zhang X, Li X, Peng Z, He Y, Chen L, Pan Q, Fang D, Chen W, Qian C, Bian X, Wang R. Zhu R, et al. PLoS One. 2012;7(2):e32170. doi: 10.1371/journal.pone.0032170. Epub 2012 Feb 23. PLoS One. 2012. PMID: 22384170 Free PMC article.
• ASCL2 induces an immune excluded microenvironment by activating cancer-associated fibroblasts in microsatellite stable colorectal cancer.

  Zhang D, Ni QQ, Liang QY, He LL, Qiu BW, Zhang LJ, Mou TY, Le CC, Huang Y, Li TT, Wang SY, Ding YQ, Jiao HL, Ye YP. Zhang D, et al. Oncogene. 2023 Sep;42(38):2841-2853. doi: 10.1038/s41388-023-02806-3. Epub 2023 Aug 17. Oncogene. 2023. PMID: 37591954 Free PMC article.
• R-spondin1/Wnt-enhanced Ascl2 autoregulation controls the self-renewal of colorectal cancer progenitor cells.

  Ye J, Liu S, Shang Y, Chen H, Wang R. Ye J, et al. Cell Cycle. 2018;17(8):1014-1025. doi: 10.1080/15384101.2018.1469874. Epub 2018 Jun 25. Cell Cycle. 2018. PMID: 29886802 Free PMC article.